17 February 2024 false Taxfiler 2024.6 15498463business:PrivateLimitedCompanyLtd2024-02-172025-02-28 154984632024-02-16 154984632024-02-172025-02-28 15498463business:AuditExempt-NoAccountantsReport2024-02-172025-02-28 15498463business:FilletedAccounts2024-02-172025-02-28 154984632025-02-28 15498463business:Director12024-02-172025-02-28 15498463business:RegisteredOffice2024-02-172025-02-28 15498463core:WithinOneYear2025-02-28 15498463core:ShareCapitalcore:PreviouslyStatedAmount2025-02-28 15498463core:RetainedEarningsAccumulatedLossescore:PreviouslyStatedAmount2025-02-28 15498463core:PreviouslyStatedAmount2025-02-28 15498463business:SmallEntities2024-02-172025-02-28 15498463countries:EnglandWales2024-02-172025-02-28 15498463core:ComputerEquipment2024-02-172025-02-28 15498463core:ComputerEquipment2024-02-16 15498463core:ComputerEquipment2025-02-28 15498463business:OrdinaryShareClass12024-02-172025-02-28 iso4217:GBP xbrli:shares xbrli:pure
Company Registration No. 15498463 (England and Wales)
Uevolve Healthcare Uk Ltd Unaudited accounts for the period from 17 February 2024 to 28 February 2025
Uevolve Healthcare Uk Ltd Unaudited accounts Contents
Page
- 2 -
Uevolve Healthcare Uk Ltd Company Information for the period from 17 February 2024 to 28 February 2025
Director
Sidharth Shankar Khandelwal
Company Number
15498463 (England and Wales)
Registered Office
164 New Cavendish Street London W1W 6YT England
- 3 -
Uevolve Healthcare Uk Ltd Statement of financial position as at 28 February 2025
2025 
Notes
£ 
Fixed assets
Tangible assets
1,500 
Current assets
Debtors
18,940 
Cash at bank and in hand
26,285 
45,225 
Creditors: amounts falling due within one year
(25,043)
Net current assets
20,182 
Net assets
21,682 
Capital and reserves
Called up share capital
1,000 
Profit and loss account
20,682 
Shareholders' funds
21,682 
For the period ending 28 February 2025 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies. The members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.
The director acknowledges his responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.
These accounts have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies' regime and in accordance with the provisions of FRS 102 Section 1A - Small Entities. The profit and loss account has not been delivered to the Registrar of Companies.
The financial statements were approved by the Board and authorised for issue on 22 April 2025 and were signed on its behalf by
Sidharth Shankar Khandelwal Director Company Registration No. 15498463
- 4 -
Uevolve Healthcare Uk Ltd Notes to the Accounts for the period from 17 February 2024 to 28 February 2025
1
Statutory information
Uevolve Healthcare Uk Ltd is a private company, limited by shares, registered in England and Wales, registration number 15498463. The registered office is 164 New Cavendish Street, London, W1W 6YT, England.
2
Compliance with accounting standards
The accounts have been prepared in accordance with the provisions of FRS 102 Section 1A Small Entities. There were no material departures from that standard.
3
Accounting policies
The principal accounting policies adopted in the preparation of the financial statements are set out below and have been consistently applied within the same accounts.
Basis of preparation
The accounts have been prepared under the historical cost convention as modified by the revaluation of certain fixed assets.
Presentation currency
The accounts are presented in £ sterling.
Turnover
Turnover is measured at the fair value of the consideration received or receivable, excluding discounts, rebates, value added tax and other sales taxes. Turnover from the sale of goods is recognised when goods have been delivered to customers such that risks and rewards of ownership have transferred to them. Turnover from the rendering of services is recognised by reference to the stage of completion of the contract. The stage of completion of a contract is measured by comparing the costs incurred for work performed to date to the total estimated contract costs.
Tangible fixed assets and depreciation
Tangible assets are included at cost less depreciation and impairment. Depreciation has been provided at the following rates in order to write off the assets over their estimated useful lives:
Computer equipment
25% on cost
Deferred taxation
Deferred tax arises as a result of including items of income and expenditure in taxation computations in periods different from those in which they are included in the company's accounts. Deferred tax is provided in full on timing differences which result in an obligation to pay more (or less) tax at a future date, at the average tax rates that are expected to apply when the timing differences reverse, based on current tax rates and laws. Deferred tax assets and liabilities are not discounted.
Research and development
Expenditure on research and development is written off in the year in which it is incurred.
Foreign exchange
Monetary assets and liabilities in foreign currencies are translated into sterling at the rates of exchange ruling at the balance sheet date. Transactions in foreign currencies are translated into sterling at the rates of exchange ruling at the date of the transaction. Exchange differences are taken into account in arriving at the operating profit.
- 5 -
Uevolve Healthcare Uk Ltd Notes to the Accounts for the period from 17 February 2024 to 28 February 2025
4
Tangible fixed assets
Computer equipment 
£ 
Cost or valuation
At cost 
At 17 February 2024
- 
Additions
2,000 
At 28 February 2025
2,000 
Depreciation
Charge for the period
500 
At 28 February 2025
500 
Net book value
At 28 February 2025
1,500 
5
Debtors
2025 
£ 
Amounts falling due within one year
Trade debtors
17,486 
Accrued income and prepayments
1,454 
18,940 
6
Creditors: amounts falling due within one year
2025 
£ 
Trade creditors
216 
Taxes and social security
4,499 
Other creditors
15,633 
Accruals
4,695 
25,043 
7
Share capital
2025 
£ 
Allotted, called up and fully paid:
1,000 Ordinary shares of £1 each
1,000 
Shares issued during the period:
1,000 Ordinary shares of £1 each
1,000 
8
Transactions with related parties
Included in other creditors is a sum of £Nil owed to Mr Sidharth Shankar Khandelwal , a sole director of the company.
9
Average number of employees
During the period the average number of employees was 1.
- 6 -